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ABSTRACT 
According to current knowledge on collagen fibril-
logenesis, collagen fibrils are formed by a cooperative 
process involving lateral fusion of small protofibrils. 
Almost all the experimental research, however, was 
carried out on tendon collagen, whose fibrils are 
characterized by approximately straight subfibrils. 
By contrast, in most tissues the collagen fibril sub-
units follow a helical course in which geometrical 
constraints prevent lateral fusions, thereby implying 
a different mechanism where collagen fibrils grow by 
addition of individual microfibrils rather than by 
lateral fusion of pre-assembled subfibrils. The proc-
ess at the origin of these fibrils may provide a simple, 
automatic explanation for the remarkable uniformity 
in fibrils size observed in most tissues without re-
quiring the intervention of unknown mechanisms of 
diameter control. Other mechanisms of growth con-
trol remain indispensable to terminate the fibril-
logenesis process in tendons and ligaments. 
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1. INTRODUCTION 
Fibrillar collagens account for approximately a third of 
the total body proteins. Their molecules, a coiled coil of 
three individual polypeptide chains, ultimately form dis-
crete fibrils of indeterminate length and widely variable 
diameter [1]. 
The diameter of collagen fibrils plays a central role in 
the functional behaviour of the diverse connective tis-
sues [2,3], but the mechanisms controlling fibril size 
remain unsettled. A number of different molecules and 
factors have been shown to influence the collagen fibril 
growth, including the relative content of collagen III [4] 
and V [5], the terminal globular domains of the collagen 
molecule (especially the N-terminal propeptide [6]), 
cross-links [7], fibril-associated non-helical collagens (or 
FACITs), COMP [8], small proteoglycans such as 
decorin [9], fibromodulin [10], lumican [11] and bigli-
can [12], but also tenascin [13], perlecan [14], matrilin 
[15] and thrombospondin [16]. Although there is some 
evidence for most of these factors, none of them is by 
itself entirely consistent with all the experimental obser-
vations. In particular none was able to explain why in 
most tissues the fibril growth is very effectively con-
trolled so that the collagen fibrils size is highly uniform 
and distributed along a narrow Gaussian curve, while in 
other, and often adjoining, tissues the collagen fibrils are 
large and inhomogeneous with a distinctive multimodal 
distribution. The difference between these two classes is 
so great that it may seem not unreasonable to hypothe-
size that two entirely different mechanisms are at work 
in different tissues. 
It is important to bear in mind that these two classes 
of fibrils represent two mutually exclusive subfibrillar 
architectures [17-19]. Historically, research on fibril ar-
chitecture and fibrillogenesis has been carried out almost 
exclusively on the large variable fibrils of tendons, 
whose subfibrils run almost parallel to the fibril axis. 
These fibrils come into being by means of a cooperative 
mechanism involving the lateral fusion of smaller proto-
fibrils [20]: the process has been directly observed in 
vivo, and in vitro even mature fibrils of type I collagen 
retain the ability to fuse laterally in thick clumps unless 
fusion is inhibited by small proteoglycans [21]. 
Much less attention has been paid to the smaller uni-
modal fibrils. Corneal fibrils have been painstakingly 
demonstrated to be made of discrete subunits, corre-
sponding in size to the microfibrils of Smith [22] and 
laid out in concentric layers [23,24] where they wind in 
a right-handed helix. In each layer the microfibrils wind 
at a constant angle of 15 to 17 degrees with respect to 
the fibril axis, the precise measurement depending on the 
technique used. As a consequence, the axial D-period is 
reduced from the usual 67 nm to approximately 64 nm 
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(64  67cos(17º)) [25], and the tilt-caused shear brings 
adjoining microfibrils in such a position to allow the 
formation of a peculiar covalent cross-link involving a 
histidine residue [26]. The diameter of these “helical” 
fibrils varies from tissue to tissue but remains extremely 
uniform in each location. Other tissues with small het-
erogeneous fibrils (such as blood vessels and nerve 
sheaths) have been less studied, but the facts that they all 
share an identical winding angle, the same shortened 
D-period and an equally narrow diameter distribution are 
strongly suggestive of an identical substructure. This 
subfibrillar architecture, defined as a constant angle he-
lix and originally entertained in 1989 [19], is not easy to 
visualize: the pitch of the helix that each subfibril de-
scribes around the fibril axis is 2πrtan(/2-) (where  
is the angle with respect to the fibril axis) and therefore, 
all other factors being constant, it is variable with the 
radius.  
On the other hand, this design automatically guaran-
tees that all the microfibrils have an identical axi-
ally-projected length of 64 nm (an essential condition for 
the distinctive banding pattern of collagen to appear). 
The only alternative model, the constant pitch helix, re-
quires axial subunits to be compressed and peripheral 
ones stretched in order to be consistent with ultrastruc-
tural data [19]. Moreover, because of its layered struc-
ture, the constant angle helix has the additional advan-
tage of being consistent with the discrete distribution of 
diameter values reported in some tissues [2]. 
This structure has another simple but critical conse-
quence which, to the best of our knowledge, has not 
been noticed so far: such helical fibrils cannot possibly 
undergo lateral fusion since the adjoining microfibrils of 
two parallel fibrils always wind in opposite directions 
(Figure 1). This, of course, also holds true for antiparal-
lel fibrils, which would be unable to merge anyway. It is 
an everyday observation that wire ropes are made of 
strands that never merge: for a helically-wound fibril to 
merge with another similar fibril, it would have to be 
entirely unwound and rewound, a process made unlikely 
by the substantial variation of free energy it implies.  
In other words, while the large heterogenous size of 
tendon collagen fibrils may emerge as the result of a 
random lateral fusion of protofibrils taking place during 
the first phases of fibrillogenesis (until this process is 
inhibited by fibril-bound proteogycans and/or by some 
other mechanism), the slender fibrils of cornea, blood 
vessels and sheaths must simply precipitate from a su-
persaturated solution of collagen molecules. Under these 
conditions each growing fibril competes with its 
neighbours for the available subunits until all these have 
been depleted. The extracellular environment being the 
same for all forming fibrils in a given location, they all  
 
Figure 1. The adjoining microfibrils of two parallel fibrils run 
in opposite directions (red arrows) preventing any lateral fu-
sion. Model developed on Alias|Wavefront Maya 6.0.1 running 
under IRIX on a Silicon Graphics Fuel R14000/600. 
 
end up of a similar size without requiring (at least in 
principle) any external limiting factor. Again, this phe-
nomenon is readily observed in everyday life: for in-
stance in snowflakes or hailstones which, albeit variable 
from place to place, tend to have the same size in the 
same location. 
2. MODEL DEVELOPMENT 
A simple program was developed to test this hypothesis. 
The program essentially tries to obtain a graphical simu-
lation of the cross-section of a bundle of cylindrical fi-
brils. Each individual pixel represents a 4-nm microfibril; 
the program typically manages a 500 x 500 pixel arena, 
corresponding to a 2000  2000 nm field, which is 
enough to create a few hundred fibrils, which in turn can 
represent a significant sample.  
The program can be outlined as follows: 
1) A new microfibril is created in a random position 
Copyright © 2010 SciRes.                                                                             JBiSE 
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(x,y). 
 
2) If no fibril lies within a given “capture distance” (a 
user-defined value set by the Field parameter – see Fig-
ure 2), then the microfibril itself becomes a new fibril; 
else the microfibril coalesces with its nearest fibril, 
whose radius is recomputed accordingly. 
3) A test is made to check if the fibril, which has now 
grown larger, collides with any other fibril. If a collision 
is found:  
4) If fibril merging is enabled (via the Merge switch) 
then the two fibrils merge into a new one, whose radius 
and position are recomputed; else the colliding fibril is 
simply displaced. 
5) If fibril merging is enabled, a random function 
(whose probability increases with the fibril size) can 
block the fibril, preventing other subsequent fusions. 
6) Point (3) is recursively repeated until no further 
collisions are found. 
The whole process is iterated up to the desired volume 
fraction (set by the Fraction parameter). 
As in any simulation, a few arbitrary assumptions had 
to be made:  
Figure 2. The graphical output of the fibrillogenesis simulation 
program. When fibril fusion is enabled, the microfibrils form 
fibrils with a widely variable distribution of diameters, ranging 
from 4 nm to over 450 nm as observed in tendons and liga-
ments. 
1) In the real world the capture distance is likely to 
depend on a complex interplay of several factors which 
are impossible to quantify precisely. One of them is the 
creation rate of the microfibrils (if the rate is low enough 
there is more time for the Brownian motion to bring new 
microfibrils into contact with a preexisting fibril). In 
software this parameter was empirically set to a fraction 
of a collagen molecule length. 
 
 
2) The volume fraction of collagen is also variable 
from tissue to tissue. In our simulation this parameter is 
not really important, since the fibrils in excess simply 
exit the simulation arena and are lost, so it was set to 
100%.  
3) The termination condition of point (5) was intro-
duced to prevent fusion-enabled fibrils merging into a 
single huge unit, that is precisely what happens in vitro 
when no control factors are present [21]. 
3. RESULTS 
Even under these relatively crude conditions the pictures 
show a clear similarity with the actual micrographs. If 
the lateral fusion is allowed then the process leads to the 
appearance of widely heterogenous aggregates (Figure 2) 
quite similar to the fibrils found in tendons and liga-
ments. 
If fibril fusion is precluded, the simulation yields a 
field of remarkably uniform fibrils (Figure 3). In this 
case the process even mimics the apparent alignment of 
fibrils in rows, often visible in electron micrographs 
(compare these pictures with Figure 5 of Ref. [1]).  
Figure 3. When the lateral fusion is disabled, all other pa-
rameters remaining constant, the result is a field of remarkably 
uniform fibrils with a diameter centered around 100 nm in a 
narrow distribution. The simulation software was written in 
tandard Java 2 and runs on the same workstation as Figure 1. It must be stressed that the software is intended to just  s 
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Figure 4. Exploring the parameter space in our simulation changes the average diameters but does not alter their distribution. The 
two panels above show the diameter distribution (in nm) obtained when the lateral fusion is not allowed: changing the two 
user-defined parameters always produces a family of Gaussian curves, centered on different values but with a similar shape. The 
two panels below depict the multi-peak distribution obtained under the same conditions if the lateral fusion is enabled. 
 
reveal a general trend, and does not claim to be a com-
prehensive reconstruction of the fibrillogenesis process. 
It is noteworthy, however, that varying all the parameters 
influenced the average diameter of fibrils but did not 
alter the diameter distribution: always a smooth Gaus-
sian in one case, a multi-peak range in the other (Figure 
4). 
4. DISCUSSION 
Our results suggest that the remarkable uniformity in 
size that collagen fibrils show in some tissues does not 
require the introduction of some unknown, stringent 
mechanism of diameter control, but emerges spontane-
ously as the result of a simple structural constraint. The 
most effective mechanism of growth control is one that 
does not depend on external interventions: the helical 
substructure of these fibrils is both a necessary and a 
sufficient condition for their diameter uniformity. 
These results do not imply than propeptides or pro-
teoglycans or other molecules have no part in limiting 
the lateral accretion of the fibrils; quite the opposite. The 
role, for instance, of SLRPs in this process is undeniable 
[21], and even in our simulation a termination condition 
had to be introduced if lateral fusion was allowed. 
Rather, these results imply that the absence of external 
growth-limiting factors may affect different fibrils (and 
hence different tissues) in different ways. In tissues such 
as tendons whose fibrils have straight microfibrils, the 
proteoglycans (and/or propeptides or other molecules) 
are necessary to terminate lateral fibril aggregation 
whereas in tissues such as cornea, nerve sheaths and 
interstitial collagen of parenchymatous organs whose 
fibrils have helical microfibrils they are not. Therefore a 
DCN -/- organism, for instance, can be expected to show 
fibrillar alterations in tendons but not in cornea. And this 
is exactly what is found in experimental observations 
[9].  
For historical and technical reasons connective tissue 
research is so deeply entrenched in the study of tendon 
and bone that the mere existence of fibrils with helical 
subunits took many years to emerge. Although inde-
pendently confirmed by freeze-etching [17], cross-links 
analysis [26], SEM and AFM [27], electron tomography 
[23] and X-ray diffraction [24], the evidence has yet to 
Copyright © 2010 SciRes.                                                                             JBiSE 
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find its way into histology textbooks. We must take care 
not to repeat the original sin of studying only tendons, 
and then ascribe what we found here to all other tissues.  
Fibrils with helical subfibrils are the most common 
among our different tissues. Our data indicate that the 
current knowledge on the fibrillogenesis process, all 
gained on tendons, does not apply to these fibrils, and 
that new research is required.  
The next primary objective will be the identification 
of the molecular switch controlling the initiation of one 
or the other subfibrillar architecture, and which has so 
far eluded detection. Fibrillogenesis is a delicate process 
which can be influenced by myriad causes, some of 
which do not even remain to make up the final product.  
Perhaps the most promising candidate appears now 
type V collagen. Almost since its discovery the type V 
has associated with the control of fibril diameter [28], 
and more recently it seems to be essential for fibril for-
mation in vivo: homozygote engineered organisms lack-
ing type V die at embryonic day 10 of cardiovascular 
failure, while heterozygotes are viable but lack about 
half their collagen fibrils [29].  
It seems therefore not unreasonable to hypothesize 
that type V collagen is involved in the formation of 
slender, uniform fibrils in cornea, blood vessels and 
sheaths, but obviously not in tendon and ligaments 
where it appears only in traces. Further research is un-
derway. 
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